OptimumBank Holdings, Inc. filings document the regulatory record for a Florida bank holding company that owns OptimumBank, OptimumFunding, LLC and OptimumFinance, LLC. Its 8-K reports cover unaudited operating results, financial condition presentations, Regulation FD disclosures, executive leadership changes, subsidiary formation, and material equity transactions.
Proxy and annual meeting filings document director elections, auditor ratification, shareholder voting results, and amendments to the company's capital structure, including authorization of nonvoting common stock. Other disclosures address exchanges of Series B Convertible Preferred Stock into common stock, governance matters, and the capital and operating structure of the bank and non-bank lending subsidiaries.
OptimumBank Holdings, Inc. entered into and completed an exchange agreement with shareholder Michael Blisko on January 27, 2026. Under this agreement, Mr. Blisko exchanged 65 shares of the company’s Series B Convertible Preferred Stock for 531,178 newly issued shares of common stock. The exchange was conducted as an unregistered transaction under the Securities Act of 1933, relying on an exemption including Section 3(a)(9). The company’s common stock trades on the NYSE American under the symbol OPHC.
OptimumBank Holdings director Michael Blisko reported a large equity restructuring. On January 27, 2026, he exchanged 65 shares of Series B Convertible Preferred Stock for 531,178 shares of common stock at a stated price of $0.00 per share.
The filing notes this was an exchange under an Exchange Agreement dated January 27, 2026, rather than a standard conversion under the preferred stock terms. After the transaction, Blisko directly holds 1,135,823 common shares and 615 Series B preferred shares, plus additional indirect common holdings in a spouse’s IRA, his own IRA, a daughter’s account, and a UTMA account.
OptimumBank Holdings, Inc. filed a current report to note that it released a presentation describing aspects of its unaudited results of operations and financial condition for, and at the end of, the year ended December 31, 2025. The presentation, dated January 20, 2026, is furnished as an exhibit under items covering results of operations and Regulation FD disclosure.
The company states that this information, including the exhibits, is being furnished rather than filed, which means it is not subject to certain Exchange Act liabilities and will only be incorporated into other filings if specifically referenced.
Optimum Bank Holdings, Inc. has a shareholder planning to sell up to 39,304 shares of its common stock through broker Charles Schwab on or after 01/05/2026. The planned sale has an aggregate market value of $166,648.00, compared with 11,533,943 common shares outstanding for the company.
The seller originally acquired 40,000 common shares on 08/15/2021 in a cash purchase directly from Optimum Bank Holdings, Inc. under a transaction labeled as a purchase from the issuer. The notice also states that the person for whose account the shares are to be sold represents that they are not aware of any material adverse, non‑public information about the issuer’s current or prospective operations.
OptimumBank Holdings, Inc. director Michael Blisko reported an open-market purchase of the company’s common stock. On 12/04/2025, he bought 7,600 shares of OptimumBank Holdings common stock at a price of $4.09 per share in a transaction coded "P" for a purchase. Following this transaction, he beneficially owns 604,645 shares of OptimumBank Holdings common stock in direct form. This Form 4/A reflects activity by a board-level insider increasing his direct equity position in the company.
OptimumBank Holdings, Inc. reported an insider stock transaction by a director. On 12/04/2025, the director sold 7,600 shares of OptimumBank common stock at a price of $4.09 per share, coded as a sale transaction. After this trade, the director directly beneficially owned 604,645 shares of the company’s common stock. The filing was made on Form 4 and indicates the transaction involved only non-derivative common stock, with no derivative securities reported.
AllianceBernstein L.P. filed a Schedule 13G reporting beneficial ownership in OptimumBank Holdings Inc. (OPHC). The firm disclosed 652,860 shares of common stock, representing 5.6% of the class as of 09/30/2025.
AllianceBernstein reports sole voting power over 652,860 shares and sole dispositive power over 652,860 shares. The holdings were acquired solely for investment purposes on behalf of client discretionary investment advisory accounts. The filing certifies the securities were not acquired to change or influence control of OPHC.
OptimumBank Holdings, Inc. furnished a Form 8‑K announcing it issued a press release with unaudited results of operations and financial condition for the nine‑month period ended September 30, 2025.
The press release is included as Exhibit 99.1. The company states the information is furnished and not filed under the Exchange Act, and is not subject to Section 18 liability nor incorporated by reference unless specifically referenced.
OptimumBank Holdings (OPHC) reported stronger Q3 2025 results. Net earnings were $4,323 for the quarter and $11,795 for the nine months. Net interest income rose to $11,048 from $8,962 as deposit costs eased, with interest expense at $5,273 versus $6,372. Basic EPS was $0.37 and diluted EPS $0.18.
Total assets reached $1,083,043 as of September 30, 2025, driven by cash and equivalents of $235,086 and net loans of $802,812. Total deposits were $959,487. Federal Home Loan Bank advances were $0, down from $50,000 at year‑end. Stockholders’ equity increased to $116,888.
Credit quality metrics improved: the allowance for credit losses was $10,018 and nonaccrual loans were $2,975, down from $7,576 at December 31, 2024. Accumulated other comprehensive loss narrowed to $(4,753) from $(5,570). Shares outstanding were 11,533,943 as of November 10, 2025.
OptimumBank Holdings, Inc. (OPHC) furnished an investor presentation outlining aspects of its unaudited results of operations and financial condition for the nine-month period ended September 30, 2025. The presentation is included as Exhibit 99.1.
The company states this information is being furnished, not filed, and is therefore not subject to liability under Section 18 of the Exchange Act, nor incorporated by reference into other filings unless specifically referenced. OPHC’s common stock trades on the NYSE American.